Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
City of Hope Medical Center
City of Hope Medical Center
University of Chicago
Medical College of Wisconsin
OHSU Knight Cancer Institute
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Miami
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Cancer Research UK
Nantes University Hospital
Mayo Clinic
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Stanford University
University Hospital Heidelberg
Fred Hutchinson Cancer Center
City of Hope Medical Center
PrECOG, LLC.
University of Nebraska
University of Nebraska
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
University of Nebraska
OHSU Knight Cancer Institute
Emory University
Memorial Sloan Kettering Cancer Center
Columbia University
University College, London
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Swiss Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
Mayo Clinic
Chinese PLA General Hospital
Louisiana State University Health Sciences Center Shreveport
Fred Hutchinson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute